Rapid evolving into acute myeloid leukemia in a patient with multiple myeloma and concurrent myelodysplasia after VTD therapy.
Gu ZH et al. Int J Clin Exp Med. 2015 Jun 15;8(6):10105-10108.

Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma.
Vincent L et al. Blood Cancer J. 2015 Aug 21;5:e341. doi: 10.1038/bcj.2015.48.

Hematopoietic cell transplantation in patients with medication-related osteonecrosis of the jaws.
Mawardi H et al. Biol Blood Marrow Transplant. 2015 Aug 21. pii: S1083-8791(15)00550-9. doi: 10.1016/j.bbmt.2015.08.021. [Epub ahead of print].

Soluble Vascular Endothelial Growth Factor and the Risk of Venous Thromboembolism in Patients with Cancer – Results from the Vienna Cancer and Thrombosis Study.
Posch F et al. Clin Cancer Res. 2015 Aug 24. pii: clincanres.3358.2014. [Epub ahead of print].

Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
Ecotière L et al. Nephrol Dial Transplant. 2015 Aug 19. pii: gfv283. [Epub ahead of print].

Association of osteolytic lesions, bone mineral loss and trabecular sclerosis with prevalent vertebral fractures in patients with multiple myeloma.
Borggrefe J et al. Eur J Radiol. 2015 Aug 6. pii: S0720-048X(15)30064-4. doi: 10.1016/j.ejrad.2015.07.024. [Epub ahead of print].

Validation of the Spine Oncology Study Group Outcomes Questionnaire to assess quality of life in patients with metastatic spine disease.
Janssen SJ et al. Spine J. 2015 Aug 5. pii: S1529-9430(15)01197-3. doi: 10.1016/j.spinee.2015.07.456. [Epub ahead of print].

Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis.
Shah N et al. Biol Blood Marrow Transplant. 2015 Aug 5. pii: S1083-8791(15)00516-9. doi: 10.1016/j.bbmt.2015.07.036. [Epub ahead of print].

Life-threatening bowel perforation while on thalidomide-based triplet regimen for multiple myeloma: a retrospective case series.
Sriskandarajah P et al. Br J Haematol. 2015 Aug 7. doi: 10.1111/bjh.13630. [Epub ahead of print].

Unusual Manifestations of Essential Monoclonal Gammopathy. II. Simulation of the Insulin Autoimmune Syndrome.
Lichtman MA et al. Rambam Maimonides Med J. 2015 Jul 30;6(3). doi: 10.5041/RMMJ.10212.

Towards a better understanding of the relationship between side effects of analgesia and quality of life in patients with multiple myeloma.
Niscola P et al. Support Care Cancer. 2015 Aug 4. [Epub ahead of print].

Pulmonary Nodule and Subcutaneous Abscess in a 71-Year-Old Patient With Multiple Myeloma.
Beresford R et al. Clin Infect Dis. 2015 Aug 15;61(4):661-2. doi: 10.1093/cid/civ213.

Pulmonary Nodule and Subcutaneous Abscess in a 71-Year-Old Patient With Multiple Myeloma.
[No authors listed]. Clin Infect Dis. 2015 Aug 15;61(4):626. doi: 10.1093/cid/civ206.

Gastroenterology: Esophageal perforation in a patient with multiple myeloma- the ‘bone’ connection.
Gajendran M et al. J Gastroenterol Hepatol. 2015 Aug;30(8):1227. doi: 10.1111/jgh.12939.

Transiently Pink-Tinged Serum in a Patient With Multiple Myeloma and Anemia Undergoing Lenalidomide Treatment.
Wedel W et al. Am J Clin Pathol. 2015 Aug;144(2):329-32. doi: 10.1309/AJCP4RB3YNAWZPZN.